Journal
JOURNAL OF CONTROLLED RELEASE
Volume 190, Issue -, Pages 424-439Publisher
ELSEVIER
DOI: 10.1016/j.jconrel.2014.04.012
Keywords
Bioreducible polymer; Gene; Cardiovascular disease; Diabetes; Oncolytic adenovirus; Targeting
Funding
- NIH [HL065477, CA107070, DK07703, DK085075]
Ask authors/readers for more resources
Most currently available cationic polymers have significant acute toxicity concerns such as cellular toxicity, aggregation of erythrocytes, and entrapment in the lung capillary bed, largely due to their poor biocompatibility and non-degradability under physiological conditions. To develop more intelligent polymers, disulfide bonds are introduced in the design of biodegradable polymers. Herein, the sustained innovations of biomimetic nano-sized constructs with bioreducible poly(disulfide amine)s demonstrate a viable clinical tool for the treatment of cardiovascular disease, anemia, diabetes, and cancer. (C) 2014 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available